![Donald Lee Drakeman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Donald Lee Drakeman
Vorstandsvorsitzender bei GenPharm International LLC
Aktive Positionen von Donald Lee Drakeman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GenPharm International LLC
![]() GenPharm International LLC BiotechnologyHealth Technology GenPharm International, Inc. manufactures biopharmaceutical products. The company works towards the application of transgenic animal technology to the development of human antibody products, which are used for therapeutic uses. It was founded in 1988 and is located in San Jose, CA. | Vorstandsvorsitzender | - | - |
Präsident | - | - | |
New Jersey Commission on Science & Technology | Vorsitzender | - | - |
Advent Venture Partners LLP
![]() Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01.01.2007 | - |
Gem Pharmaceuticals LLC
![]() Gem Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Gem Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company that develops anthracycline derivatives used to eliminate cardiotoxicity side effect in chemotherapeutics. The company is headquartered in Birmingham, AL. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Donald Lee Drakeman
Ehemalige bekannte Positionen von Donald Lee Drakeman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IDM Pharma, Inc.
![]() IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - | 01.06.2007 |
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Vorstandsvorsitzender | 01.01.1987 | 05.11.2006 |
Gründer | 01.01.1987 | 05.11.2006 | |
Präsident | 01.01.1987 | 05.11.2006 | |
Princeton University | Corporate Officer/Principal | - | - |
GENMAB A/S | Gründer | 01.01.1999 | - |
Zymeworks BC, Inc.
![]() Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | 02.07.2010 | - |
Independent Dir/Board Member | 02.07.2010 | - | |
░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░ | - | - |
Ausbildung von Donald Lee Drakeman
The Trustees of Columbia University in The City of New York | Graduate Degree |
Dartmouth College | Undergraduate Degree |
Princeton University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Vereinigtes Königreich | 2 |
Kanada | 2 |
Operativ
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Founder | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 4 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GENMAB A/S | Health Technology |
Private Unternehmen | 9 |
---|---|
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Advent Venture Partners LLP
![]() Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Celldex Therapeutics, Inc. (Old)
![]() Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Celldex Therapeutics, Inc. discovers, develops and commercialized novel immunotherapeutics. It offers treatment for cancer, infectious diseased and immune system disorders. The company was founded in May, 2003 and is headquartered in Philipsburg, NJ. | Health Technology |
Zymeworks BC, Inc.
![]() Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
GenPharm International LLC
![]() GenPharm International LLC BiotechnologyHealth Technology GenPharm International, Inc. manufactures biopharmaceutical products. The company works towards the application of transgenic animal technology to the development of human antibody products, which are used for therapeutic uses. It was founded in 1988 and is located in San Jose, CA. | Health Technology |
4-Antibody AG
![]() 4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Health Technology |
IDM Pharma, Inc.
![]() IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Health Technology |
New Jersey Commission on Science & Technology | Government |
Gem Pharmaceuticals LLC
![]() Gem Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Gem Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company that develops anthracycline derivatives used to eliminate cardiotoxicity side effect in chemotherapeutics. The company is headquartered in Birmingham, AL. | Health Technology |
- Börse
- Insiders
- Donald Lee Drakeman
- Erfahrung